DOI: 10.1055/s-00000017

Experimental and Clinical Endocrinology & Diabetes

References

Zhou JB, Bai L, Wang Y. et al
The benefits and risks of DPP4-inhibitors vs. sulfonylureas for patients with type 2 diabetes: Accumulated evidence from randomised controlled trial.

Int J Clin Pract 2016;
70: 132-141

Download Bibliographical Data

Search in:
Access: